Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Knowledge and Competence Support Platform Improves POC Testing

By LabMedica International staff writers
Posted on 10 Feb 2009
A knowledge and competence support platform is designed to improve and test user competency in point-of-care (POC) testing through online courses and examination. More...


POC is a growing field and is increasingly governed by regulatory requirements including competence assessment and training on a regular basis. Training in many countries is emerging as a compulsory expectation in POC management.

Continuous quality assurance of POC means ongoing recertification of standards. The Cobas academy is suitable for providing courses and exams for recertification to large numbers of staff. Knowledgeable and competent end users can deliver better use and greater reliability of POC devices, fewer errors in each of the analytic stages, and more appropriate use of lab resources.

Cobas academy's primary function is to test user competency after the initial face-to-face training. Accessible on the hospital intranet, it offers the user an optional pre-test that generates a study plan to focus only on required areas. The platform offers greater flexibility in training delivery and the opportunity to involve a larger group of staff.

Roche Diagnostics (Rotkreuz, Switzerland) launched the new knowledge and competence support platform, which currently offers three courses cobas b 221, Accu-Chek Inform, and Accu-Chek Inform II. Cobas academy is available in countries that proffer cobas IT (information technology) 1000 solutions.

Roche is a developer of in vitro diagnostics (IVD), drugs for cancer, transplantation, and virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders, and diseases of the central nervous system (CNS).

Related Links:
Roche



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.